Financial Results Presentation(Fiscal Year Ending 2026/Mar 3Q)

FY2024

FY2025

Change 3Q

cumulative

1Q

2Q

3Q

3Q

cumulative

1Q

2Q

3Q

3Q

cumulative

Net sales

26.1

26.9

28.5

81.5

28.2

29.2

30.2

87.6

6.1

7.5%

Operating profit

ROS％

3.9

15.0%

3.4

12.8%

4.5

15.7%

11.8

14.5%

4.3

15.2%

5.2

17.7%

5.5

18.2%

14.9

17.0%

3.1

26.4%

EBITDA

EBITDA margin

5.8

22.3%

5.4

19.9%

6.4

22.6%

17.6

21.6%

6.4

22.7%

7.4

25.5%

7.9

26.2%

21.8

24.8%

4.1

23.4%

Ordinary profit

4.8

3.0

5.5

13.2

4.3

4.8

6.1

15.2

2.0

15.5%

Net profit

3.3

2.2

4.0

9.4

3.1

3.7

28.2

35.1

25.7

272.7%

Electronic Materials

• Special Glass sales were strong and contributed to earnings, driven by continued robust demand for uses in AI servers.

Sales and profit increased

Medical

• Some impact from preferential treatment for products made in China, but sales of in vitro diagnostic reagents were stable. We also continued strengthening the foundation.

Sales and profit increased

Composite Materials

• Sales were flat year on year.The same period of the previous year had been affected by cost increases associated with periodic repairs to production facilities and other factors.

Sales and profit increased

Materials Solution

• Although price increases contributed to sales, there was an impact from higher costs of raw materials, etc.

Sales and profit decreased

Insulation Materials

• Sales for residential remained weak, in addition to which cost rose due to the impact of periodic repairs to production facilities.

Sales and profit decreased